Cardiovascular & Hematological Agents in Medicinal Chemistry

Cardiovascular & Hematological Agents in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1871-5257
ISSN (Online): 1875-6182

Back Subscribe
Research Article

MOTS-c as a Potential Diagnostic-prognostic Biomarker for Myocardial Infarction

Author(s): Abdulkadir Cakmakorcid of author and Burak Yazgan*

Volume 23, Issue 3, 2025

Published on: 09 May, 2025

Page: [209 - 222] Pages: 14

DOI: 10.2174/0118715257368076250324041741

Price: $65

Become a Editorial Board Member
Become a Reviewer
Become a Editor
Become a Section Editor

Abstract

Background: Myocardial infarction (MI) is a disease characterised by myocardial necrosis due to acute and prolonged ischaemic hypoxia in the coronary arteries. MOTS-c is a mitochondrial- derived peptide that has been reported to have protective effects on cardiac tissue. Although this peptide is thought to be decreased in various diseases and can serve as a potential biomarker, current studies remain limited.

Objectives: This study aimed to evaluate how the post-treatment process affects circulating MOTS- c peptide levels in myocardial infarction patients.

Methods: For this purpose, patients without obstructive coronary lesions on angiography were included in the control group, while those with significant obstructive coronary lesions on angiography were included in the infarction group. Routine biochemistry tests were performed using an autoanalyzer. Besides, serum MOTS-c levels were measured using ELISA.

Results: Our findings showed CRP, ESR, and troponin I levels to be higher in the MI group compared to the control group. Also, there was no significant change in MOTS-c levels between the control and the MI group, while time-dependent changes (day 0, day 3, and day 30) occurred within the MI group. However, a negative correlation was found between MOTS-c and platelet levels in the MI group at day 0 (r: -0.4417, p =0.0450). Similarly, MOTS-c was found to be negatively correlated with troponin I in the MI group at day 3 (r: -0.4571, p =0.0372).

Conclusion: The negative correlation of MOTS-c level with both platelet and troponin I has shown that this peptide may contribute to the diagnostic and therapeutic evaluation of the MI process along with other parameters.

Keywords: Cardiovascular diseases, inflammation, myocardial infarction, MDPs, MOTS-c, troponin I.

Graphical Abstract

[1]
Diehm, C.; Lange, S.; Darius, H.; Pittrow, D.; von Stritzky, B.; Tepohl, G.; Haberl, R.L.; Allenberg, J.R.; Dasch, B.; Trampisch, H.J. Association of low ankle brachial index with high mortality in primary care. Eur. Heart J., 2006, 27(14), 1743-1749.
[http://dx.doi.org/10.1093/eurheartj/ehl092] [PMID: 16782720]
[2]
Roth, G.A.; Mensah, G.A.; Johnson, C.O.; Addolorato, G.; Ammirati, E.; Baddour, L.M.; Barengo, N.C.; Beaton, A.Z.; Benjamin, E.J.; Benziger, C.P.; Bonny, A.; Brauer, M.; Brodmann, M.; Cahill, T.J.; Carapetis, J.; Catapano, A.L.; Chugh, S.S.; Cooper, L.T.; Coresh, J.; Criqui, M.; DeCleene, N.; Eagle, K.A.; Emmons-Bell, S.; Feigin, V.L.; Fernández-Solà, J.; Fowkes, G.; Gakidou, E.; Grundy, S.M.; He, F.J.; Howard, G.; Hu, F.; Inker, L.; Karthikeyan, G.; Kassebaum, N.; Koroshetz, W.; Lavie, C.; Lloyd-Jones, D.; Lu, H.S.; Mirijello, A.; Temesgen, A.M.; Mokdad, A.; Moran, A.E.; Muntner, P.; Narula, J.; Neal, B.; Ntsekhe, M.; Moraes de Oliveira, G.; Otto, C.; Owolabi, M.; Pratt, M.; Rajagopalan, S.; Reitsma, M.; Ribeiro, A.L.P.; Rigotti, N.; Rodgers, A.; Sable, C.; Shakil, S.; Sliwa-Hahnle, K.; Stark, B.; Sundström, J.; Timpel, P.; Tleyjeh, I.M.; Valgimigli, M.; Vos, T.; Whelton, P.K.; Yacoub, M.; Zuhlke, L.; Murray, C.; Fuster, V.; Roth, G.A.; Mensah, G.A.; Johnson, C.O.; Addolorato, G.; Ammirati, E.; Baddour, L.M.; Barengo, N.C.; Beaton, A.; Benjamin, E.J.; Benziger, C.P.; Bonny, A.; Brauer, M.; Brodmann, M.; Cahill, T.J.; Carapetis, J.R.; Catapano, A.L.; Chugh, S.; Cooper, L.T.; Coresh, J.; Criqui, M.H.; DeCleene, N.K.; Eagle, K.A.; Emmons-Bell, S.; Feigin, V.L.; Fernández-Sola, J.; Fowkes, F.G.R.; Gakidou, E.; Grundy, S.M.; He, F.J.; Howard, G.; Hu, F.; Inker, L.; Karthikeyan, G.; Kassebaum, N.J.; Koroshetz, W.J.; Lavie, C.; Lloyd-Jones, D.; Lu, H.S.; Mirijello, A.; Misganaw, A.T.; Mokdad, A.H.; Moran, A.E.; Muntner, P.; Narula, J.; Neal, B.; Ntsekhe, M.; Oliveira, G.M.M.; Otto, C.M.; Owolabi, M.O.; Pratt, M.; Rajagopalan, S.; Reitsma, M.B.; Ribeiro, A.L.P.; Rigotti, N.A.; Rodgers, A.; Sable, C.A.; Shakil, S.S.; Sliwa, K.; Stark, B.A.; Sundström, J.; Timpel, P.; Tleyjeh, I.I.; Valgimigli, M.; Vos, T.; Whelton, P.K.; Yacoub, M.; Zuhlke, L.J.; Abbasi-Kangevari, M.; Abdi, A.; Abedi, A.; Aboyans, V.; Abrha, W.A.; Abu-Gharbieh, E.; Abushouk, A.I.; Acharya, D.; Adair, T.; Adebayo, O.M.; Ademi, Z.; Advani, S.M.; Afshari, K.; Afshin, A.; Agarwal, G.; Agasthi, P.; Ahmad, S.; Ahmadi, S.; Ahmed, M.B.; Aji, B.; Akalu, Y.; Akande-Sholabi, W.; Aklilu, A.; Akunna, C.J.; Alahdab, F.; Al-Eyadhy, A.; Alhabib, K.F.; Alif, S.M.; Alipour, V.; Aljunid, S.M.; Alla, F.; Almasi-Hashiani, A.; Almustanyir, S.; Al-Raddadi, R.M.; Amegah, A.K.; Amini, S.; Aminorroaya, A.; Amu, H.; Amugsi, D.A.; Ancuceanu, R.; Anderlini, D.; Andrei, T.; Andrei, C.L.; Ansari-Moghaddam, A.; Anteneh, Z.A.; Antonazzo, I.C.; Antony, B.; Anwer, R.; Appiah, L.T.; Arabloo, J.; Ärnlöv, J.; Artanti, K.D.; Ataro, Z.; Ausloos, M.; Avila-Burgos, L.; Awan, A.T.; Awoke, M.A.; Ayele, H.T.; Ayza, M.A.; Azari, S.; B, D.B.; Baheiraei, N.; Baig, A.A.; Bakhtiari, A.; Banach, M.; Banik, P.C.; Baptista, E.A.; Barboza, M.A.; Barua, L.; Basu, S.; Bedi, N.; Béjot, Y.; Bennett, D.A.; Bensenor, I.M.; Berman, A.E.; Bezabih, Y.M.; Bhagavathula, A.S.; Bhaskar, S.; Bhattacharyya, K.; Bijani, A.; Bikbov, B.; Birhanu, M.M.; Boloor, A.; Brant, L.C.; Brenner, H.; Briko, N.I.; Butt, Z.A.; Caetano dos Santos, F.L.; Cahill, L.E.; Cahuana-Hurtado, L.; Cámera, L.A.; Campos-Nonato, I.R.; Cantu-Brito, C.; Car, J.; Carrero, J.J.; Carvalho, F.; Castañeda-Orjuela, C.A.; Catalá-López, F.; Cerin, E.; Charan, J.; Chattu, V.K.; Chen, S.; Chin, K.L.; Choi, J-Y.J.; Chu, D-T.; Chung, S-C.; Cirillo, M.; Coffey, S.; Conti, S.; Costa, V.M.; Cundiff, D.K.; Dadras, O.; Dagnew, B.; Dai, X.; Damasceno, A.A.M.; Dandona, L.; Dandona, R.; Davletov, K.; De la Cruz-Góngora, V.; De la Hoz, F.P.; De Neve, J-W.; Denova-Gutiérrez, E.; Derbew Molla, M.; Derseh, B.T.; Desai, R.; Deuschl, G.; Dharmaratne, S.D.; Dhimal, M.; Dhungana, R.R.; Dianatinasab, M.; Diaz, D.; Djalalinia, S.; Dokova, K.; Douiri, A.; Duncan, B.B.; Duraes, A.R.; Eagan, A.W.; Ebtehaj, S.; Eftekhari, A.; Eftekharzadeh, S.; Ekholuenetale, M.; El Nahas, N.; Elgendy, I.Y.; Elhadi, M.; El-Jaafary, S.I.; Esteghamati, S.; Etisso, A.E.; Eyawo, O.; Fadhil, I.; Faraon, E.J.A.; Faris, P.S.; Farwati, M.; Farzadfar, F.; Fernandes, E.; Fernandez Prendes, C.; Ferrara, P.; Filip, I.; Fischer, F.; Flood, D.; Fukumoto, T.; Gad, M.M.; Gaidhane, S.; Ganji, M.; Garg, J.; Gebre, A.K.; Gebregiorgis, B.G.; Gebregzabiher, K.Z.; Gebremeskel, G.G.; Getacher, L.; Obsa, A.G.; Ghajar, A.; Ghashghaee, A.; Ghith, N.; Giampaoli, S.; Gilani, S.A.; Gill, P.S.; Gillum, R.F.; Glushkova, E.V.; Gnedovskaya, E.V.; Golechha, M.; Gonfa, K.B.; Goudarzian, A.H.; Goulart, A.C.; Guadamuz, J.S.; Guha, A.; Guo, Y.; Gupta, R.; Hachinski, V.; Hafezi-Nejad, N.; Haile, T.G.; Hamadeh, R.R.; Hamidi, S.; Hankey, G.J.; Hargono, A.; Hartono, R.K.; Hashemian, M.; Hashi, A.; Hassan, S.; Hassen, H.Y.; Havmoeller, R.J.; Hay, S.I.; Hayat, K.; Heidari, G.; Herteliu, C.; Holla, R.; Hosseini, M.; Hosseinzadeh, M.; Hostiuc, M.; Hostiuc, S.; Househ, M.; Huang, J.; Humayun, A.; Iavicoli, I.; Ibeneme, C.U.; Ibitoye, S.E.; Ilesanmi, O.S.; Ilic, I.M.; Ilic, M.D.; Iqbal, U.; Irvani, S.S.N.; Islam, S.M.S.; Islam, R.M.; Iso, H.; Iwagami, M.; Jain, V.; Javaheri, T.; Jayapal, S.K.; Jayaram, S.; Jayawardena, R.; Jeemon, P.; Jha, R.P.; Jonas, J.B.; Jonnagaddala, J.; Joukar, F.; Jozwiak, J.J.; Jürisson, M.; Kabir, A.; Kahlon, T.; Kalani, R.; Kalhor, R.; Kamath, A.; Kamel, I.; Kandel, H.; Kandel, A.; Karch, A.; Kasa, A.S.; Katoto, P.D.M.C.; Kayode, G.A.; Khader, Y.S.; Khammarnia, M.; Khan, M.S.; Khan, M.N.; Khan, M.; Khan, E.A.; Khatab, K.; Kibria, G.M.A.; Kim, Y.J.; Kim, G.R.; Kimokoti, R.W.; Kisa, S.; Kisa, A.; Kivimäki, M.; Kolte, D.; Koolivand, A.; Korshunov, V.A.; Koulmane Laxminarayana, S.L.; Koyanagi, A.; Krishan, K.; Krishnamoorthy, V.; Kuate Defo, B.; Kucuk Bicer, B.; Kulkarni, V.; Kumar, G.A.; Kumar, N.; Kurmi, O.P.; Kusuma, D.; Kwan, G.F.; La Vecchia, C.; Lacey, B.; Lallukka, T.; Lan, Q.; Lasrado, S.; Lassi, Z.S.; Lauriola, P.; Lawrence, W.R.; Laxmaiah, A.; LeGrand, K.E.; Li, M-C.; Li, B.; Li, S.; Lim, S.S.; Lim, L-L.; Lin, H.; Lin, Z.; Lin, R-T.; Liu, X.; Lopez, A.D.; Lorkowski, S.; Lotufo, P.A.; Lugo, A.; M, N.K.; Madotto, F.; Mahmoudi, M.; Majeed, A.; Malekzadeh, R.; Malik, A.A.; Mamun, A.A.; Manafi, N.; Mansournia, M.A.; Mantovani, L.G.; Martini, S.; Mathur, M.R.; Mazzaglia, G.; Mehata, S.; Mehndiratta, M.M.; Meier, T.; Menezes, R.G.; Meretoja, A.; Mestrovic, T.; Miazgowski, B.; Miazgowski, T.; Michalek, I.M.; Miller, T.R.; Mirrakhimov, E.M.; Mirzaei, H.; Moazen, B.; Moghadaszadeh, M.; Mohammad, Y.; Mohammad, D.K.; Mohammed, S.; Mohammed, M.A.; Mokhayeri, Y.; Molokhia, M.; Montasir, A.A.; Moradi, G.; Moradzadeh, R.; Moraga, P.; Morawska, L.; Moreno Velásquez, I.; Morze, J.; Mubarik, S.; Muruet, W.; Musa, K.I.; Nagarajan, A.J.; Nalini, M.; Nangia, V.; Naqvi, A.A.; Narasimha Swamy, S.; Nascimento, B.R.; Nayak, V.C.; Nazari, J.; Nazarzadeh, M.; Negoi, R.I.; Neupane Kandel, S.; Nguyen, H.L.T.; Nixon, M.R.; Norrving, B.; Noubiap, J.J.; Nouthe, B.E.; Nowak, C.; Odukoya, O.O.; Ogbo, F.A.; Olagunju, A.T.; Orru, H.; Ortiz, A.; Ostroff, S.M.; Padubidri, J.R.; Palladino, R.; Pana, A.; Panda-Jonas, S.; Parekh, U.; Park, E-C.; Parvizi, M.; Pashazadeh Kan, F.; Patel, U.K.; Pathak, M.; Paudel, R.; Pepito, V.C.F.; Perianayagam, A.; Perico, N.; Pham, H.Q.; Pilgrim, T.; Piradov, M.A.; Pishgar, F.; Podder, V.; Polibin, R.V.; Pourshams, A.; Pribadi, D.R.A.; Rabiee, N.; Rabiee, M.; Radfar, A.; Rafiei, A.; Rahim, F.; Rahimi-Movaghar, V.; Ur Rahman, M.H.; Rahman, M.A.; Rahmani, A.M.; Rakovac, I.; Ram, P.; Ramalingam, S.; Rana, J.; Ranasinghe, P.; Rao, S.J.; Rathi, P.; Rawal, L.; Rawasia, W.F.; Rawassizadeh, R.; Remuzzi, G.; Renzaho, A.M.N.; Rezapour, A.; Riahi, S.M.; Roberts-Thomson, R.L.; Roever, L.; Rohloff, P.; Romoli, M.; Roshandel, G.; Rwegerera, G.M.; Saadatagah, S.; Saber-Ayad, M.M.; Sabour, S.; Sacco, S.; Sadeghi, M.; Saeedi Moghaddam, S.; Safari, S.; Sahebkar, A.; Salehi, S.; Salimzadeh, H.; Samaei, M.; Samy, A.M.; Santos, I.S.; Santric-Milicevic, M.M.; Sarrafzadegan, N.; Sarveazad, A.; Sathish, T.; Sawhney, M.; Saylan, M.; Schmidt, M.I.; Schutte, A.E.; Senthilkumaran, S.; Sepanlou, S.G.; Sha, F.; Shahabi, S.; Shahid, I.; Shaikh, M.A.; Shamali, M.; Shamsizadeh, M.; Shawon, M.S.R.; Sheikh, A.; Shigematsu, M.; Shin, M-J.; Shin, J.I.; Shiri, R.; Shiue, I.; Shuval, K.; Siabani, S.; Siddiqi, T.J.; Silva, D.A.S.; Singh, J.A.; Mtech, A.S.; Skryabin, V.Y.; Skryabina, A.A.; Soheili, A.; Spurlock, E.E.; Stockfelt, L.; Stortecky, S.; Stranges, S.; Suliankatchi Abdulkader, R.; Tadbiri, H.; Tadesse, E.G.; Tadesse, D.B.; Tajdini, M.; Tariqujjaman, M.; Teklehaimanot, B.F.; Temsah, M-H.; Tesema, A.K.; Thakur, B.; Thankappan, K.R.; Thapar, R.; Thrift, A.G.; Timalsina, B.; Tonelli, M.; Touvier, M.; Tovani-Palone, M.R.; Tripathi, A.; Tripathy, J.P.; Truelsen, T.C.; Tsegay, G.M.; Tsegaye, G.W.; Tsilimparis, N.; Tusa, B.S.; Tyrovolas, S.; Umapathi, K.K.; Unim, B.; Unnikrishnan, B.; Usman, M.S.; Vaduganathan, M.; Valdez, P.R.; Vasankari, T.J.; Velazquez, D.Z.; Venketasubramanian, N.; Vu, G.T.; Vujcic, I.S.; Waheed, Y.; Wang, Y.; Wang, F.; Wei, J.; Weintraub, R.G.; Weldemariam, A.H.; Westerman, R.; Winkler, A.S.; Wiysonge, C.S.; Wolfe, C.D.A.; Wubishet, B.L.; Xu, G.; Yadollahpour, A.; Yamagishi, K.; Yan, L.L.; Yandrapalli, S.; Yano, Y.; Yatsuya, H.; Yeheyis, T.Y.; Yeshaw, Y.; Yilgwan, C.S.; Yonemoto, N.; Yu, C.; Yusefzadeh, H.; Zachariah, G.; Zaman, S.B.; Zaman, M.S.; Zamanian, M.; Zand, R.; Zandifar, A.; Zarghi, A.; Zastrozhin, M.S.; Zastrozhina, A.; Zhang, Z-J.; Zhang, Y.; Zhang, W.; Zhong, C.; Zou, Z.; Zuniga, Y.M.H.; Murray, C.J.L.; Fuster, V. Global burden of cardiovascular diseases and risk factors, 1990–2019: Update from the GBD 2019 study. J. Am. Coll. Cardiol., 2020, 76(25), 2982-3021.
[http://dx.doi.org/10.1016/j.jacc.2020.11.010] [PMID: 33309175]
[3]
İstatistikleri, T.A. Index, 2019.
[4]
Anderson, J.L.; Morrow, D.A. Acute myocardial infarction. N. Engl. J. Med., 2017, 376(21), 2053-2064.
[http://dx.doi.org/10.1056/NEJMra1606915] [PMID: 28538121]
[5]
Mozaffarian, D.; Benjamin, E.J.; Go, A.S.; Arnett, D.K.; Blaha, M.J.; Cushman, M.; De Ferranti, S.; Després, J.-P.; Fullerton, H.J.; Howard, V.J. Heart disease and stroke statistics—2015 update: A report from the american heart association. Circulation, 2015, 131(4), e329-e322.
[6]
Antman, E.M. Acute myocardial infarction. In: Heart disease-A Textbook os Dardiovascular Medicine; , 1997; pp. 1184-1228.
[7]
Chen, Z.; Venkat, P.; Seyfried, D.; Chopp, M.; Yan, T.; Chen, J. Brain–heart interaction. Circ. Res., 2017, 121(4), 451-468.
[http://dx.doi.org/10.1161/CIRCRESAHA.117.311170] [PMID: 28775014]
[8]
Populations, B.H.S.; Criteria, C.S.S.H.D. HIV and disability: Updating the social security listings; National Academies Press, 2010.
[9]
Bink, N.; Mohan, V.B.; Fakirov, S. Recent advances in plastic stents: A comprehensive review. Int. J. Polym. Mater., 2021, 70(1), 54-74.
[http://dx.doi.org/10.1080/00914037.2019.1685519]
[10]
Hamm, C.W.; Bassand, J.P.; Agewall, S.; Bax, J.; Boersma, E.; Bueno, H.; Caso, P.; Dudek, D.; Gielen, S.; Huber, K.; Ohman, M.; Petrie, M.C.; Sonntag, F.; Uva, M.S.; Storey, R.F.; Wijns, W.; Zahger, D. ESC guidelines for the management of acute coronary syndromes in patients without persistent ST-segment elevation at presentation. Task force for the management of acute coronary syndromes (ACS) in patients without persistent st-segment elevation at presentation of the european society of cardiology (ESC). G. Ital. Cardiol., 2012, 13(3), 171-228.
[PMID: 22395108]
[11]
Reyes-Retana, J.A.; Duque-Ossa, L.C. Acute myocardial infarction biosensor: A review from bottom up. Curr. Probl. Cardiol., 2021, 46(3), 100739.
[http://dx.doi.org/10.1016/j.cpcardiol.2020.100739] [PMID: 33250264]
[12]
Procopio, A.; De Rosa, S.; Covello, C.; Merola, A.; Sabatino, J.; De Luca, A.; Indolfi, C.; Amato, F.; Cosentino, C. 2019 18th European Control Conference (ECC), 2019, pp 1653-1658.
[13]
Garg, P.; Morris, P.; Fazlanie, A.L.; Vijayan, S.; Dancso, B.; Dastidar, A.G.; Plein, S.; Mueller, C.; Haaf, P. Cardiac biomarkers of acute coronary syndrome: From history to high-sensitivity cardiac troponin. Intern. Emerg. Med., 2017, 12(2), 147-155.
[http://dx.doi.org/10.1007/s11739-017-1612-1] [PMID: 28188579]
[14]
Bostan, M.M.; Stătescu, C.; Anghel, L.; Șerban, I.L.; Cojocaru, E.; Sascău, R. Post-myocardial infarction ventricular remodeling biomarkers—the key link between pathophysiology and clinic. Biomolecules, 2020, 10(11), 1587.
[http://dx.doi.org/10.3390/biom10111587] [PMID: 33238444]
[15]
Hashimoto, Y.; Niikura, T.; Tajima, H.; Yasukawa, T.; Sudo, H.; Ito, Y.; Kita, Y.; Kawasumi, M.; Kouyama, K.; Doyu, M.; Sobue, G.; Koide, T.; Tsuji, S.; Lang, J.; Kurokawa, K.; Nishimoto, I. A rescue factor abolishing neuronal cell death by a wide spectrum of familial Alzheimer’s disease genes and Aβ. Proc. Natl. Acad. Sci. USA, 2001, 98(11), 6336-6341.
[http://dx.doi.org/10.1073/pnas.101133498] [PMID: 11371646]
[16]
Lee, C.; Zeng, J.; Drew, B.G.; Sallam, T.; Martin-Montalvo, A.; Wan, J.; Kim, S.J.; Mehta, H.; Hevener, A.L.; de Cabo, R.; Cohen, P. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab., 2015, 21(3), 443-454.
[http://dx.doi.org/10.1016/j.cmet.2015.02.009] [PMID: 25738459]
[17]
Kim, S.J.; Xiao, J.; Wan, J.; Cohen, P.; Yen, K. Mitochondrially derived peptides as novel regulators of metabolism. J. Physiol., 2017, 595(21), 6613-6621.
[http://dx.doi.org/10.1113/JP274472] [PMID: 28574175]
[18]
Ramanjaneya, M.; Bettahi, I.; Jerobin, J.; Chandra, P.; Abi Khalil, C.; Skarulis, M.; Atkin, S.L.; Abou-Samra, A.B. Mitochondrial-derived peptides are down regulated in diabetes subjects. Front. Endocrinol., 2019, 10, 331.
[http://dx.doi.org/10.3389/fendo.2019.00331] [PMID: 31214116]
[19]
Yazgan, B.; Türkel, İ.; Özerkliğ, B.; Atakan, M.M.; Aktitiz, S.; Koşar, Ş.N. Exercise and metabolic health: The emerging roles of novel exerkines. Curr. Protein Pept. Sci., 2022, 23(7), 437-455.
[http://dx.doi.org/10.2174/1389203723666220629163524] [PMID: 35770405]
[20]
Atakan, M.M.; Türkel, İ.; Özerkliğ, B.; Koşar, Ş.N.; Taylor, D.F.; Yan, X.; Bishop, D.J. Small peptides: Could they have a big role in metabolism and the response to exercise? J. Physiol., 2024, 602(4), 545-568.
[http://dx.doi.org/10.1113/JP283214] [PMID: 38196325]
[21]
Merry, T.L.; Chan, A.; Woodhead, J.S.T.; Reynolds, J.C.; Kumagai, H.; Kim, S.J.; Lee, C. Mitochondrial-derived peptides in energy metabolism. Am. J. Physiol. Endocrinol. Metab., 2020, 319(4), E659-E666.
[http://dx.doi.org/10.1152/ajpendo.00249.2020] [PMID: 32776825]
[22]
Yong, C.Q.Y.; Tang, B.L. A mitochondrial encoded messenger at the nucleus. Cells, 2018, 7(8), 105.
[http://dx.doi.org/10.3390/cells7080105] [PMID: 30104535]
[23]
Rochette, L.; Meloux, A.; Zeller, M.; Cottin, Y.; Vergely, C. Role of humanin, a mitochondrial-derived peptide, in cardiovascular disorders. Arch. Cardiovasc. Dis., 2020, 113(8-9), 564-571.
[http://dx.doi.org/10.1016/j.acvd.2020.03.020] [PMID: 32680738]
[24]
Dabravolski, S.A.; Nikiforov, N.G.; Starodubova, A.V.; Popkova, T.V.; Orekhov, A.N. The role of mitochondria-derived peptides in cardiovascular diseases and their potential as therapeutic targets. Int. J. Mol. Sci., 2021, 22(16), 8770.
[http://dx.doi.org/10.3390/ijms22168770] [PMID: 34445477]
[25]
Cao, X.; Li, H.; Tao, H.; Wu, N.; Yu, L.; Zhang, D.; Lu, X.; Zhu, J.; Lu, Z.; Zhu, Q. Metformin inhibits vascular calcification in female rat aortic smooth muscle cells via the AMPK-eNOS-NO pathway. Endocrinology, 2013, 154(10), 3680-3689.
[http://dx.doi.org/10.1210/en.2013-1002] [PMID: 24025223]
[26]
Li, Y.; Li, Z.; Ren, Y.; Lei, Y.; Yang, S.; Shi, Y.; Peng, H.; Yang, W.; Guo, T.; Yu, Y.; Xiong, Y. Mitochondrial-derived peptides in cardiovascular disease: Novel insights and therapeutic opportunities. J. Adv. Res., 2024, 64, 99-115.
[http://dx.doi.org/10.1016/j.jare.2023.11.018] [PMID: 38008175]
[27]
Wei, M.; Gan, L.; Liu, Z.; Liu, L.; Chang, J.R.; Yin, D.C.; Cao, H.L.; Su, X.L.; Smith, W.W. Mitochondrial-derived peptide MOTS-c attenuates vascular calcification and secondary myocardial remodeling via adenosine monophosphate-activated protein kinase signaling pathway. Cardiorenal Med., 2020, 10(1), 42-50.
[http://dx.doi.org/10.1159/000503224] [PMID: 31694019]
[28]
Qin, Q.; Delrio, S.; Wan, J.; Jay Widmer, R.; Cohen, P.; Lerman, L.O.; Lerman, A. Downregulation of circulating MOTS-c levels in patients with coronary endothelial dysfunction. Int. J. Cardiol., 2018, 254, 23-27.
[http://dx.doi.org/10.1016/j.ijcard.2017.12.001] [PMID: 29242099]
[29]
Park, K.H.; Park, W.J. Endothelial dysfunction: Clinical implications in cardiovascular disease and therapeutic approaches. J. Korean Med. Sci., 2015, 30(9), 1213-1225.
[http://dx.doi.org/10.3346/jkms.2015.30.9.1213] [PMID: 26339159]
[30]
Li, H.; Ren, K.; Jiang, T.; Zhao, G.J. MOTS-c attenuates endothelial dysfunction via suppressing the MAPK/NF-κB pathway. Int. J. Cardiol., 2018, 268, 40.
[http://dx.doi.org/10.1016/j.ijcard.2018.03.031] [PMID: 30041797]
[32]
Aydin, S.; Ugur, K.; Aydin, S.; Sahin, İ.; Yardim, M. Biomarkers in acute myocardial infarction: Current perspectives. Vasc. Health Risk Manag., 2019, 15, 1-10.
[http://dx.doi.org/10.2147/VHRM.S166157] [PMID: 30697054]
[33]
Ross, R. Atherosclerosis-an inflammatory disease. N. Engl. J. Med., 1999, 340(2), 115-126.
[http://dx.doi.org/10.1056/NEJM199901143400207] [PMID: 9887164]
[34]
Palmerini, T.; Marzocchi, A.; Marrozzini, C.; Ortolani, P.; Saia, F.; Bacchi-Reggiani, L.; Virzì, S.; Gianstefani, S.; Branzi, A. Preprocedural levels of C-reactive protein and leukocyte counts predict 9-month mortality after coronary angioplasty for the treatment of unprotected left main coronary artery stenosis. Circulation, 2005, 112(15), 2332-2338.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.105.551648] [PMID: 16203907]
[35]
Olenchock, B.A.; Wiviott, S.D.; Murphy, S.A.; Cannon, C.P.; Rifai, N.; Braunwald, E.; Morrow, D.A. Lack of association between soluble CD40L and risk in a large cohort of patients with acute coronary syndrome in OPUS TIMI-16. J. Thromb. Thrombolysis, 2008, 26(2), 79-84.
[http://dx.doi.org/10.1007/s11239-007-0156-z] [PMID: 17917707]
[36]
Armstrong, E.J.; Morrow, D.A.; Sabatine, M.S. Inflammatory biomarkers in acute coronary syndromes: Part I: Introduction and cytokines. Circulation, 2006, 113(6), e72-e75.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.105.595520] [PMID: 16476853]
[37]
Roman, R.M.; Camargo, P.V.; Borges, F.K.; Rossini, A.P.; Polanczyk, C.A. Prognostic value of myeloperoxidase in coronary artery disease: Comparison of unstable and stable angina patients. Coron. Artery Dis., 2010, 21(3), 129-136.
[http://dx.doi.org/10.1097/MCA.0b013e328333f50d] [PMID: 20305551]
[38]
Tudurachi, B.S.; Anghel, L.; Tudurachi, A.; Sascău, R.A.; Stătescu, C. Assessment of inflammatory hematological ratios (NLR, PLR, MLR, LMR and Monocyte/HDL–Cholesterol Ratio) in acute myocardial infarction and particularities in young patients. Int. J. Mol. Sci., 2023, 24(18), 14378.
[http://dx.doi.org/10.3390/ijms241814378] [PMID: 37762680]
[39]
Yuan, S.; Li, L.; Pu, T.; Fan, X.; Wang, Z.; Xie, P.; Li, P. The relationship between NLR, LDL-C/HDL-C, NHR and coronary artery disease. PLoS One, 2024, 19(7), e0290805.
[http://dx.doi.org/10.1371/journal.pone.0290805] [PMID: 38985788]
[40]
Gosav, E.M.; Tanase, D.M.; Buliga-Finis, O.N.; Rezuș, I.I.; Morariu, P.C.; Floria, M.; Rezus, C. The prognostic role of the neutrophil-to-lymphocytes ratio in the most frequent cardiovascular diseases: An update. Life, 2024, 14(8), 985.
[http://dx.doi.org/10.3390/life14080985] [PMID: 39202727]
[41]
Guasti, L.; Castiglioni, L.; Maroni, L.; Marino, F.; Squizzato, A.; Ageno, W.; Gianni, M.; Gaudio, G.; Grandi, A.; Cosentino, M.; Venco, A.; Dentali, F. Neutrophils and clinical outcomes in patients with acute coronary syndromes and/or cardiac revascularisation. Thromb. Haemost., 2011, 106(10), 591-599.
[http://dx.doi.org/10.1160/TH11-02-0096] [PMID: 21866299]
[42]
Wang, X.; Zhang, G.; Jiang, X.; Zhu, H.; Lu, Z.; Xu, L. Neutrophil to lymphocyte ratio in relation to risk of all-cause mortality and cardiovascular events among patients undergoing angiography or cardiac revascularization: A meta-analysis of observational studies. Atherosclerosis, 2014, 234(1), 206-213.
[http://dx.doi.org/10.1016/j.atherosclerosis.2014.03.003] [PMID: 24681815]
[43]
Easmin, T.; Khalequzzaman, M.; Ahmed, M.; Hasan, M.M. Association between neutrophil to lymphocyte ratio and severity of coronary artery disease in acute myocardial infarction patients. Bangladesh Heart J., 2024, 39(1), 1-9.
[http://dx.doi.org/10.3329/bhj.v39i1.70655]
[44]
Zahorec, R. Neutrophil-to-lymphocyte ratio, past, present and future perspectives. Bratisl. Med. J., 2021, 122(7), 474-488.
[http://dx.doi.org/10.4149/BLL_2021_078] [PMID: 34161115]
[45]
Yazgan, B.; Sozen, E.; Karademir, B.; Ustunsoy, S.; Ince, U.; Zarkovic, N.; Ozer, N.K. CD36 expression in peripheral blood mononuclear cells reflects the onset of atherosclerosis. Biofactors, 2018, 44(6), 588-596.
[http://dx.doi.org/10.1002/biof.1372] [PMID: 28677864]
[46]
Sozen, E.; Yazgan, B.; Sahin, A.; Ince, U.; Ozer, N.K. High cholesterol diet-induced changes in Oxysterol and scavenger receptor levels in heart tissue. Oxid. Med. Cell. Longev., 2018, 2018(1), 8520746.
[http://dx.doi.org/10.1155/2018/8520746] [PMID: 30008986]
[47]
Bozaykut, P.; Karademir, B.; Yazgan, B.; Sozen, E.; Siow, R.C.M.; Mann, G.E.; Ozer, N.K. Effects of vitamin E on peroxisome proliferator-activated receptor γ and nuclear factor-erythroid 2-related factor 2 in hypercholesterolemia-induced atherosclerosis. Free Radic. Biol. Med., 2014, 70, 174-181.
[http://dx.doi.org/10.1016/j.freeradbiomed.2014.02.017] [PMID: 24583459]
[48]
Reynolds, J.C.; Lai, R.W.; Woodhead, J.S.T.; Joly, J.H.; Mitchell, C.J.; Cameron-Smith, D.; Lu, R.; Cohen, P.; Graham, N.A.; Benayoun, B.A.; Merry, T.L.; Lee, C. MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis. Nat. Commun., 2021, 12(1), 470.
[http://dx.doi.org/10.1038/s41467-020-20790-0] [PMID: 33473109]
[49]
Yang, Y.; Gao, H.; Zhou, H.; Liu, Q.; Qi, Z.; Zhang, Y.; Zhang, J. The role of mitochondria-derived peptides in cardiovascular disease: Recent updates. Biomed. Pharmacother., 2019, 117, 109075.
[http://dx.doi.org/10.1016/j.biopha.2019.109075] [PMID: 31185388]
[50]
Kim, S.J.; Mehta, H.H.; Wan, J.; Kuehnemann, C.; Chen, J.; Hu, J.F.; Hoffman, A.R.; Cohen, P. Mitochondrial peptides modulate mitochondrial function during cellular senescence. Aging, 2018, 10(6), 1239-1256.
[http://dx.doi.org/10.18632/aging.101463] [PMID: 29886458]
[51]
Lee, C.; Kim, K.H.; Cohen, P. MOTS-c: A novel mitochondrial-derived peptide regulating muscle and fat metabolism. Free Radic. Biol. Med., 2016, 100, 182-187.
[http://dx.doi.org/10.1016/j.freeradbiomed.2016.05.015] [PMID: 27216708]
[52]
Mendelsohn, A.R.; Larrick, J.W. Mitochondrial-derived peptides exacerbate senescence. Rejuvenation Res., 2018, 21(4), 369-373.
[http://dx.doi.org/10.1089/rej.2018.2114] [PMID: 30058454]
[53]
Zhai, D.; Ye, Z.; Jiang, Y.; Xu, C.; Ruan, B.; Yang, Y.; Lei, X.; Xiang, A.; Lu, H.; Zhu, Z.; Yan, Z.; Wei, D.; Li, Q.; Wang, L.; Lu, Z. MOTS-c peptide increases survival and decreases bacterial load in mice infected with MRSA. Mol. Immunol., 2017, 92, 151-160.
[http://dx.doi.org/10.1016/j.molimm.2017.10.017] [PMID: 29096170]
[54]
Tang, M.; Su, Q.; Duan, Y.; Fu, Y.; Liang, M.; Pan, Y.; Yuan, J.; Wang, M.; Pang, X.; Ma, J.; Laher, I.; Li, S. The role of MOTS-c-mediated antioxidant defense in aerobic exercise alleviating diabetic myocardial injury. Sci. Rep., 2023, 13(1), 19781.
[http://dx.doi.org/10.1038/s41598-023-47073-0] [PMID: 37957221]
[55]
Hill, S.; Sataranatarajan, K.; Van Remmen, H. Role of signaling molecules in mitochondrial stress response. Front. Genet., 2018, 9, 225.
[http://dx.doi.org/10.3389/fgene.2018.00225] [PMID: 30042784]
[56]
Camici, P.G.; Crea, F. Coronary microvascular dysfunction. N. Engl. J. Med., 2007, 356(8), 830-840.
[http://dx.doi.org/10.1056/NEJMra061889] [PMID: 17314342]
[57]
Crea, F.; Camici, P.G.; Bairey Merz, C.N. Coronary microvascular dysfunction: An update. Eur. Heart J., 2014, 35(17), 1101-1111.
[http://dx.doi.org/10.1093/eurheartj/eht513] [PMID: 24366916]
[58]
Niccoli, G.; Scalone, G.; Lerman, A.; Crea, F. Coronary microvascular obstruction in acute myocardial infarction. Eur. Heart J., 2016, 37(13), 1024-1033.
[http://dx.doi.org/10.1093/eurheartj/ehv484] [PMID: 26364289]
[59]
Rochette, L.; Rigal, E.; Dogon, G.; Malka, G.; Zeller, M.; Vergely, C.; Cottin, Y. Mitochondrial-derived peptides: New markers for cardiometabolic dysfunction. Arch. Cardiovasc. Dis., 2022, 115(1), 48-56.
[http://dx.doi.org/10.1016/j.acvd.2021.10.013] [PMID: 34972639]
[60]
Bolignano, D.; Greco, M.; Presta, P.; Duni, A.; Zicarelli, M.; Mercuri, S.; Pappas, E.; Lakkas, L.; Musolino, M.; Naka, K.K.; Misiti, R.; Foti, D.P.; Andreucci, M.; Coppolino, G.; Dounousi, E. The mitochondrial-derived peptide MOTS-c may refine mortality and cardiovascular risk prediction in chronic hemodialysis patients: A multicenter cohort study. Blood Purif., 2024, 53(10), 824-837.
[http://dx.doi.org/10.1159/000540303] [PMID: 39111290]
[61]
Asil, H.; Demiryürek, A.T.; Düzen, I.V.; Büyükcelebi, O.; Saracaloglu, A.; Demirkiran, C.; Demiryürek, Ş. Effects of empagliflozin and dapagliflozin on serum humanin, MOTS-c levels, nitrosative stress, and ferroptosis parameters in diabetic patients with heart failure. Eur. J. Pharmacol., 2024, 982, 176934.
[http://dx.doi.org/10.1016/j.ejphar.2024.176934] [PMID: 39182552]

Rights & Permissions Print Cite